Study Title: A Phase II Study of FOLFOX combined with Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma. Big Ten Cancer Research Consortium: BTCRC-GI15-015
 

• Closed to Accrual at:
  • University of Illinois Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • Michigan State University Breslin Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Rutgers Cancer Institute of New Jersey
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03283761
  • Big Ten CRC News Release

Study Contact: studies@hoosiercancer.org; (317) 921-2050.